logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure GPS-3. Last month prevalence of cannabis among the age group of 15 to 24 years, measured by national surveys


Data are from the most recent national surveys available in each country.

Some countries use a slightly different age range to the EMCDDA standard age range for young adults. Variations in age ranges may slighly influence disparities between countries.

Belgium: 2004; 15-24 y. n=

Bulgaria: 2005; 18-24 y. n=173

Czech Republic: 2004; 18-24 y. n=586

Denmark: 2005; 16-24 y. n=1434

Germany: 2003; 18-24 y. n=1891

Estonia: 2003; 15-24 y. n=329

Ireland: 2002/03; 15-24 y. n=

Greece: 2004; 15-24 y. n=1785

Spain: 2005-06; 15-24 y. n=8188

France: 2005; 15-24 y. n=4662

Italy: 2005; 15-24 y. n=9006

Cyprus: 2006; 15-24 y. n=969

Latvia: 2003; 15-24 y. n=

Lithuania: 2004; 15-24 y. N=923

Luxembourg: 1998; 15-24 y. n=

Hungary: 2003; 18-24 y. n=943

Netherlands: 2005; 15-24 y. n=

Austria: 2004; 15-24 y. n=959

Poland: 2002; 16-24 y. n=

Portugal: 2001; 15-24 y. n=3099

Slovakia: 2004; 15-24 y. n=307

Finland: 2004; 15-24 y. n=494

Sweden: 2006; 16-24 y. n=7014

UK (E&W): 2005/06; 16-24 y. n=5892

Norway: 2004; 15-24 y. n=645


SB2006: Figure GPS-3.

See also Table GPS-0.

See also 'General notes for interpreting data' on the Explanatory notes and help page.


Reitox national reports 2006, taken from population surveys, reports or scientific articles

Page last updated: Thursday, 15 November 2007